Telix Pharmaceuticals to Present at Jefferies Healthcare Conference

    NEXT STORY
    Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
    PREV STORY
    Aptose Announces Closing of Public Offering of Common Shares
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cytokinetics Reports Fourth Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News

    Translate Bio to Present at Jefferies Virtual Healthcare Conference

    author_avatar
    NASDAQ Market News

    Global Delirium Management Market Is Anticipated Grow at a CAGR of 5.6% from 2021 to 2030

    author_avatar
    NASDAQ Market News